Share

Breaking down the barriers to drug development

Dr. Francoise Meunier, EORTC Director General, Sir Michael Rawlins, former chair of NICE, and Robert Strieter, Novartis Institutes for Biomedical Research discuss translational medicine in respiratory disease in Prof. Peter Barnes’ latest instalment of ERS Vision. The film looks at ways to break down the barriers that obstruct and delay the development of new medicines at every stage of the discovery process.

Leading experts in the field tackle issues such as data protection, risk management, protocol development and European regulations, and emphasise the importance of developing active collaborations between the different stakeholders involved in the drug development process.

Back to news list

Related News

  • Meet the new EORTC Board

  • We are pleased to announce the release of the EORTC 2023 Annual Report

  • Dr Denis Lacombe, EORTC CEO, appointed stakeholder co-chair of ACT EU advisory group

  • Clinical Trials Day 2024: a Q&A on pragmatic clinical trials

  • EORTC/EMA workshop suggests an international way forward for treatment optimisation studies

  • EORTC’s Participation at the ESTRO Congress 2024

  • EORTC: Advancing research and treatment for rare cancers

  • EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration

  • Appointment of Malte Peters as EORTC Strategic Alliance Officer

  • Unique series of workshops in partnership with the European Medicines Agency (EMA)